Degeneration of substantia nigra in chronic Parkinson's disease visualized by transcranial color-coded real-time sonography

Neurology. 1995 Jan;45(1):182-4. doi: 10.1212/wnl.45.1.182.

Abstract

To detect morphologic abnormalities in Parkinson's disease (PD), we examined 30 patients with PD and 30 age- and sex-matched nonparkinsonian controls by transcranial color-coded real-time sonography (TCCS). In 12 severely affected PD patients, the echogenicity of the substantia nigra was distinctly increased. In the remaining 18 PD patients and in all controls, the substantia nigra was poorly visualized or nondetectable by TCCS. The degree of hyperechogenicity of the substantia nigra closely correlated with the severity and duration of PD (p < 0.001). The increased echogenicity of the substantia nigra notably results from nigral gliosis and reflects the stage of degeneration.

Publication types

  • Clinical Trial
  • Comparative Study
  • Controlled Clinical Trial

MeSH terms

  • Aged
  • Antiparkinson Agents / therapeutic use
  • Female
  • Humans
  • Male
  • Neurologic Examination
  • Parkinson Disease / diagnostic imaging*
  • Parkinson Disease / drug therapy
  • Parkinson Disease / physiopathology
  • Substantia Nigra / anatomy & histology
  • Substantia Nigra / diagnostic imaging*
  • Substantia Nigra / pathology
  • Ultrasonography, Doppler, Transcranial*

Substances

  • Antiparkinson Agents